Twin Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.18M | Sell |
|
|||||
|
2024
Q3 | $2.68M | Sell |
|
|||||
|
2024
Q2 | $2.76M | Buy |
|
|||||
|
2024
Q1 | $2.45M | Sell |
|
|||||
|
2023
Q4 | $2.52M | Sell |
|
|||||
|
2023
Q3 | $2.21M | Sell |
|
|||||
|
2023
Q2 | $2.39M | Sell |
|
|||||
|
2023
Q1 | $2.22M | Sell |
|
|||||
|
2022
Q4 | $3.07M | Sell |
|
|||||
|
2022
Q3 | $3.08M | Sell |
|
|||||
|
2022
Q2 | $3.02M | Buy |
|
|||||
|
2022
Q1 | $1.69M | Buy |
|
|||||
|
2021
Q4 | $1.41M | Buy |
|
|||||
|
2021
Q3 | $939K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $1.95M | Sell |
|
|||||
|
2018
Q3 | $8.72M | Buy |
|
|||||
|
2018
Q2 | $7.44M | Buy |
|
|||||
|
2018
Q1 | $7.08M | Buy |
|
|||||
|
2017
Q4 | $2.81M | Buy |
|